(Q48824499)

15 February 2018

title

The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze (English)

1 reference

15 February 2018

1 reference

P Chopin

1

1 reference

15 February 2018

M Briley

series ordinal

2

1 reference

15 February 2018

publication date

1 January 1993

1 reference

15 February 2018

published in

Psychopharmacology

1 reference

15 February 2018

volume

110

1 reference

15 February 2018

issue

4

1 reference

15 February 2018

page(s)

409-414

1 reference

15 February 2018

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02244646

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244646

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244646

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02244646

Cholecystokinin antagonism by benzodiazepines in the food intake in mice.

21 January 2018

1 reference

12 December 2020

Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects

1 reference

12 December 2020

Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat

1 reference

12 December 2020

Reversal of antinociceptive effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788.

1 reference

12 December 2020

Anxiolytic effects of CCK-B antagonists

1 reference

12 December 2020

Effects of anxiolytic and anxiogenic drugs on exploratory activity in a simple model of anxiety in mice

1 reference

12 December 2020

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

12 December 2020

Two brain cholecystokinin receptors: implications for behavioral actions

1 reference

12 December 2020

Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones

1 reference

12 December 2020

Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1, 4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 2. Evaluation of its tolerance and dependence producing potential and of its effects on benzodiazepine wi

1 reference

12 December 2020

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

1 reference

12 December 2020

Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain.

1 reference

12 December 2020

Effects of PK 8165, a partial benzodiazepine receptor agonist, on cholecystokinin-induced activation of hippocampal pyramidal neurons: a microiontophoretic study in the rat.

1 reference

12 December 2020

Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.

1 reference

12 December 2020

Does the benzodiazepine antagonist Ro 15-1788 reverse the actions of picrotoxin and pentylenetetrazole on social and exploratory behaviour?

1 reference

12 December 2020

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

12 December 2020

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

12 December 2020

Possible involvement of the CCK receptor in the benzodiazepine antagonism to CCK in the mouse brain

1 reference

12 December 2020

Reversal of increased anxiety during benzodiazepine withdrawal: evidence for an anxiogenic endogenous ligand for the benzodiazepine receptor

1 reference

12 December 2020

GABAergic neurons containing CCK-8-like and/or VIP-like immunoreactivities in the rat hippocampus and dentate gyrus

1 reference

12 December 2020

Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.

1 reference

12 December 2020

The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors

1 reference

12 December 2020

Inhibition of hypothermic effect of cholecystokinin by benzodiazepines and a benzodiazepine antagonist, Ro 15-1788, in mice

1 reference

12 December 2020

Cholecystokinin antagonism by beta-carboline esters in the central nervous system in mice

1 reference

12 December 2020

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

12 December 2020

Beta-carbolines selectively antagonize the cholecystokinin action in isolated guinea-pig gallbladder muscle

1 reference

12 December 2020

Cholecystokinin and anxiety

1 reference

12 December 2020

Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists

1 reference

12 December 2020

Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02244646

1 reference

15 February 2018

1 reference

15 February 2018